Azlocillin pharmacokinetics in patients with cystic fibrosis.

The pharmacokinetics of azlocillin were studied in 10 cystic fibrosis patients, ranging in age from 11 to 28 years. The patients received a 9- to 23-day course of 350 mg of azlocillin per kg in four or six divided daily doses in combination with am aminoglycoside. Blood and urine samples were collec...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Antimicrob Agents Chemother
Päätekijät:	Bosso, J A, Saxon, B A, Herbst, J J, Matsen, J M
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 1984
Aiheet:	Research Article
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185602/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6732230/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.25.5.630
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!